🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Transplant rejection occurs when a patient's body does not recognize the ne...
Status
Completed
Location
University of Wisconsin - Department of Medicine
Start Date
2003-11
Trial ID
NCT00078559
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
This is an open label, single-center, randomized phase IV pilot study of st...
Status
Terminated
Location
Northwestern University/Northwestern Memorial Hospital
Start Date
2005-04
Trial ID
NCT00166712
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as pentostatin, work in differe...
Status
Completed
Location
Holden Comprehensive Cancer Center at University of Iowa
Start Date
2008-07
Trial ID
NCT00669318
Treatments Being Tested
The objectives of this study are to determine the efficacy and safety of BE...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2016-02
Trial ID
NCT02411084
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy before a donor stem cell transp...
Status
Terminated
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2005-05
Trial ID
NCT00818961
This is a clinical trial that will compare survival and sickle related outc...
Status
Completed
Location
Benioff Children's Hospital at Oakland
Start Date
2017-03-16
Trial ID
NCT02766465
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
This phase I trial is studying the side effects and best dose of alemtuzuma...
Status
Terminated
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2008-11
Trial ID
NCT00947388
Treatments Being Tested